Allianca Saude e Participacoes SA
Allianca Saude e Participacoes SA has a debt-to-equity ratio of 0.87, indicating a moderate level of leverage, and a current ratio of 1.04, suggesting limited short-term liquidity cushion. The company's free cash flow is negative at -108.36 million BRL, and operating cash flow is also negative at -41.02 million BRL, signaling cash flow constraints. The company's return on equity is -11.24%, and return on assets is -4.26%, both significantly below the industry norms for healthcare providers, indicating poor profitability and asset utilization. These metrics suggest the company is underperforming relative to its peers in generating returns for shareholders and managing its asset base effectively. Allianca Saude e Participacoes SA's revenue is concentrated in a single business segment, with no disclosed geographic diversification, which increases exposure to sector-specific and regional risks. The company's capital expenditures are -99.39 million BRL, indicating a reduction in investment in long-term assets. The company's revenue growth is not disclosed, but the negative net income of -123.09 million BRL and declining cash flows suggest a challenging growth trajectory. The company's risk assessment indicates medium liquidity risk and low dilution risk, but the negative net cash position after subtracting total debt is a key flag. Recent events and filings do not provide specific details on strategic initiatives or operational changes, but the company's financial performance and cash flow issues suggest a need for operational or strategic adjustments.
Business. Allianca Saude e Participacoes SA provides healthcare services and operates in the pharmaceuticals segment, generating revenue primarily through service provision and product sales.
Classification. The company is classified under the Healthcare Facilities & Services industry within the Healthcare Services & Equipment business sector, with a high confidence level of 0.92.
- Allianca Saude e Participacoes SA is experiencing negative returns on equity and assets, indicating poor profitability.
- The company has a moderate debt-to-equity ratio but faces liquidity constraints with a current ratio of 1.04.
- Revenue is concentrated in a single segment, increasing exposure to sector-specific risks.
- Free cash flow and operating cash flow are negative, signaling cash flow challenges.
- The company's liquidity risk is medium, and dilution risk is low, but the negative net cash position is a concern.
- # RATIONALES
- {
- "margin_outlook_rationale": "The company's negative return on equity and assets indicates declining profitability, driven by poor cost management and revenue generation.",
- Net cash is negative after subtracting total debt.